This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Acadia Healthcare (ACHC)

Tipranks - Tipranks - Fri Jul 31, 6:14AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Humana (HUM), Boston Scientific (BSX) and Acadia Healthcare (ACHC).

Claim 55% Off TipRanks

Humana (HUM)

In a report released yesterday, Erin Wright from Morgan Stanley maintained a Sell rating on Humana, with a price target of $249.00. The company’s shares closed last Wednesday at $365.41.

According to TipRanks.com, Wright is a 5-star analyst with an average return of 16.1% and a 64.9% success rate. Wright covers the Healthcare sector, focusing on stocks such as BrightSpring Health Services, Inc., Elanco Animal Health, and Idexx Laboratories. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Humana with a $410.39 average price target.

See today’s best-performing stocks on TipRanks >>

Boston Scientific (BSX)

RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Boston Scientific yesterday and set a price target of $70.00. The company’s shares closed last Wednesday at $46.04.

According to TipRanks.com, Chadha is a 1-star analyst with an average return of -0.2% and a 48.4% success rate. Chadha covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Inspire Medical Systems, and Zimmer Biomet Holdings. ;'>

Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $65.53, a 53.6% upside from current levels. In a report issued on July 14, TipRanks – DeepSeek also upgraded the stock to Buy with a $49.00 price target.

Acadia Healthcare (ACHC)

In a report released today, Ben Hendrix from RBC Capital maintained a Buy rating on Acadia Healthcare, with a price target of $31.00. The company’s shares closed last Wednesday at $27.35.

According to TipRanks.com, Hendrix is a 5-star analyst with an average return of 8.8% and a 56.8% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Sonida Senior Living. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Acadia Healthcare with a $32.79 average price target, representing a -0.4% downside. In a report issued on July 20, Guggenheim also maintained a Buy rating on the stock with a $38.00 price target.

Read More on HUM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).